Gibraltar company snaps up Bod Science low-dose CBD clinical research data by Steve Jones January 30, 2025January 30, 2025 Biortica Agrimed takeover target, Bod Science, has sold a trio of intellectual property (IP) rights, including […]
Green Farmers parent set to list on ASX as deal with Bod moves closer by Steve Jones March 21, 2024March 21, 2024
Bod strikes deal to keep trading as creditor claims rise beyond A$6m by Steve Jones December 13, 2023December 13, 2023
Bod Science plots another capital raise as expanded product range set to launch by Steve Jones October 31, 2023April 30, 2024
Bod eyes opportunities beyond cannabis as Aqua Phase tech passes second bioavailability test by Martin Lane September 27, 2023April 30, 2024
Bod Science eyes new revenue streams after reporting heavy loss by Steve Jones August 30, 2023August 30, 2023
Study delivers ‘new chapter’ for Bod as Aqua Phase tech shows its worth by Steve Jones July 26, 2023April 30, 2024
Bod Science to test drug-delivery tech on psychiatric medication by Steve Jones May 31, 2023April 30, 2024
Hopes rising at Bod Science over commercial prospects for Aqua Phase by Steve Jones May 23, 2023April 30, 2024
Bod Science submits ethics approval for bioavailability study by Steve Jones March 28, 2023April 30, 2024
